2-Hydroxy-3-Methoxy-3,3-Diphenylpropanoic Acid CAS 178306-51-9 Purity ≥99.0% (HPLC) Hoobkas

Lus piav qhia luv luv:

Lub npe: 2-Hydroxy-3-Methoxy-3,3-Diphenylpropanoic Acid

CAS: 178306-51-9 Nr

Cov tsos mob: Dawb los yog Off-White hmoov

Purity: ≥99.0% (HPLC)

Intermediate of (CAS: 177036-94-1) Kev kho mob Pulmonary Arterial Hypertension (PAH)

Inquiry: alvin@ruifuchem.com

Xa email rau peb

Product Detail

Yam khoom

Khoom cim npe

Nqe lus piav qhia:

Kev Lag Luam Kev Lag Luam (CAS: 177036-94-1) Cov Neeg Nruab Nrab cuam tshuam:
CAS: 177036-94-1 Nr
Tom ntej: Methyl 2-Hydroxy-3-Methoxy-3,3-Diphenylpropanoate CAS: 178306-47-3
Tom ntej: 2-Hydroxy-3-Methoxy-3,3-Diphenylpropanoic Acid CAS: 178306-51-9
(S)-2-Hydroxy-3-Methoxy-3,3-Diphenylpropionic Acid CAS: 178306-52-0
L-Proline Methyl Ester Hydrochlorid CAS: 2133-40-6
Tom ntej: 4,6-Dimethyl-2-(Methylsulfonyl)pyrimidine CAS: 35144-22-0

Chemical Properties:

Tshuaj npe	2-Hydroxy-3-Methoxy-3,3-Diphenylpropanoic Acid
CAS Nr	178306-51-9
CAT Number	Qauv: RF-PI161
Tshuag xwm txheej	Nyob rau hauv Tshuag, ntau lawm Scale mus txog Tons
Molecular Formula	C16H16O4
Molecular Luj	272.3 ib
Qhov ntom	1.248 ib
Hom	Ruifu Tshuaj

Specifications:

Yam khoom	Specifications
Qhov tshwm sim	Dawb los yog Off-White hmoov
Purity	≥99.0% (HPLC)
Moisture (KF)	≤ 1.00%
Ib leeg Impurity	≤0.50%
Tag nrho cov impurities	≤ 1.00%
Test Standard	Enterprise Standard
Kev siv	API API (CAS: 177036-94-1)

Pob & Cia:

Pob: Lub raj mis, Aluminium ntawv ci hnab, 25kg / Nruas, los yog raws li tus neeg yuav tsum tau muaj

Cia txias:Khaws rau hauv cov thawv ntim khoom ntawm qhov chaw txias thiab qhuav;Tiv thaiv los ntawm lub teeb thiab noo noo

Qhov zoo:

FAQ:

Daim ntawv thov:

Shanghai Ruifu Chemical Co., Ltd. yog cov chaw tsim khoom thiab cov chaw muag khoom ntawm 2-Hydroxy-3-Methoxy-3,3-Diphenylpropanoic Acid (CAS: 178306-51-9) nrog cov khoom zoo, nws yog qhov tseem ceeb ntawm API (CAS) : 177036-94-1).CAS: 177036-94-1 Nr.yog ib qho kev xaiv endothelin-A (ETA) receptor antagonist qhia rau kev kho qhov ncauj ntawm cov neeg mob nrog pulmonary arterial hypertension (PAH), txhawm rau txhim kho kev tawm dag zog lub cev thiab ncua sijhawm kho mob.Nws yog tus thib peb ET-receptor antagonist los ua lag luam rau qhov kev qhia no tom qab bosentan thiab sitaxsentan.PAH yog ib yam kab mob uas tsis tshua muaj ntawm cov hlab ntsws me me uas tshwm sim los ntawm vascular proliferation thiab kho dua tshiab, uas ua rau muaj kev nce ntxiv hauv cov hlab ntsws tsis zoo thiab cov hlab ntsha pulmonary siab, thiab thaum kawg, txoj cai ventricular tsis ua haujlwm thiab tuag ntxov ntxov.Cov tsos mob thaum ntxov ntawm PAH muaj xws li pib ua pa luv, nkees, palpitation, edema, thiab ua tsis taus pa.